Cerebral Palsy Hip Health Related Quality of Life

NCT01773161 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2018-01-10

No results posted yet for this study

Summary

Children with cerebral palsy are at an increased risk of having their hips move partially or completely out of joint. This can cause pain and restrict movement at the hip, making sitting in a wheelchair uncomfortable and make personal care difficult. This condition may be treated with surgery. Surgeons use x-rays taken before and after the surgery to determine whether or not the surgery has been successful. However, it is also important to know whether the surgery has improved life from the child or the caregiver's point of view. The investigators will also evaluate if waiting for surgery affects the child. This information will be added to results from a physical exam and an evaluation of the child's x-rays for a more complete picture of how this surgery impacts the lives of our patients. It is predicted that that the health-related quality of life of children with cerebral palsy will improve following surgery.

Conditions

  • Cerebral Palsy
  • Patient Undergoing Hip Surgery
  • Quality of Life

Interventions

PROCEDURE

Cerebral palsy, post hip surgery

All subjects will undergo surgical treatment for hip subluxation or dislocation. HRQoL, radiographic, and clinical data will be measured at multiple time points.

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Kishore Mulpuri, MBBS, MS, MHSc · University of British Columbia

Eligibility

Min Age
4 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01773161 on ClinicalTrials.gov